Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical In. (“Dialco”), are pleased to announce the...
-
SOMERVILLE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Spectral Design & Test Inc. (SDT), a leading provider of embedded Memory Development platform is announcing a Family of Memory Compilers in...
-
SOMERVILLE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Spectral Design & Test Inc. (SDT), a leading provider of embedded Memory Development platform is announcing immediate availability of a third...
-
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), announced today that Dr. Paul Walker, Spectral’s Chief Executive Officer and Chris Seto,...
-
Immediately enables DIMI to be used within U.S. hospitals, clinics and skilled nursing facilitiesU.S. skilled nursing facilities market represents an estimated US$2 billion market annually TORONTO,...
-
TORONTO, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its...
-
Protocol Amendment allows for increase in TIGRIS sites to 15 while potentially accelerating patient enrolling and offsetting any COVID-19 pandemic-related delays TORONTO, Aug. 10, 2020 (GLOBE...
-
Investor Webinar to be held Monday, August 10th at 10 am Eastern Time NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO,...
-
• Early Tigris trial observations in-line with Euphrates post-hoc results • Investigator-driven studies show endotoxin levels significantly elevated in most patients with COVID-induced septic shock ...
-
Adds significant experience and strength to the Company’s commercialization focus NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO,...